World-Class CDMO Services in India for Germany

WORLD-CLASS CDMO SERVICES IN INDIA FOR GERMANY

Shilpa Pharma delivers high-quality, compliant, and scalable CDMO services from India to German pharmaceutical and biotechnology companies. As a globally trusted Contract Development and Manufacturing Organization (CDMO), our manufacturing operations are regulated by CDSCO (Central Drugs Standard Control Organization), India, and operate in full compliance with EU GMP requirements and leading global regulatory authorities including US FDA, WHO-GMP, PMDA (Japan), ANVISA (Brazil), COFEPRIS (Mexico), TGA (Australia), and KFDA (South Korea). By combining European regulatory standards, deep scientific expertise, and advanced manufacturing technologies, we help German partners accelerate product development, maintain strict regulatory compliance, and secure reliable global supply chains. Our CDMO services are designed to support German innovators with cost-efficient pharmaceutical outsourcing, robust quality management systems, and long-term strategic partnerships, enabling faster commercialization while meeting the stringent regulatory expectations of the German and EU pharmaceutical markets.

Our CDMO Specialties

Contact for End-to-End CDMO Services in India

0+

Happy Customers

0+

Projects Successfully Completed

0

Established

0+

PhD Experts Driving R&D Excellence

0+

Team Size

0+

World-Class API Manufacturing Sites

0+

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Shilpa Pharma Globally Accredited CDMO Partner

Shilpa Pharma’s facilities are certified by major international regulatory authorities, demonstrating our commitment to quality and compliance. These global accreditations make Shilpa Pharma a preferred CDMO partner for German pharmaceutical companies seeking internationally compliant manufacturing and documentation support.

Why Shilpa Pharma is Your Trusted CDMO Partner Across the Globe

As a globally accredited CDMO, Shilpa Pharma delivers end-to-end, compliant, and cost-effective solutions backed by expertise in complex chemistries and advanced formulations. Our proven quality and trusted partnerships make us the preferred choice for pharma innovators worldwide.

State-of-the-Art R&D

Advanced laboratories for formulation, biologics, and peptide research.

Global Quality Standards

GMP-compliant facilities ensuring regulatory-ready production.

Advanced Manufacturing Capabilities

High-potent APIs, continuous flow chemistry, and scalable processes.

Sustainable & Compliant Operations

Environmentally responsible practices with stringent safety protocols.

Trusted by Pharma Innovators

Reliable partnerships delivering complex projects on time and within budget.

CMO Contract Manufacturing Organization India to Germany

As a trusted Contract Manufacturing Organization (CMO), Shilpa Pharma delivers precision, quality, and compliance in commercial production for German pharmaceutical companies. Our state-of-the-art facilities in India are equipped to handle everything from small-batch production to high-volume manufacturing, ensuring consistent product quality and reliable supply.

We specialize in manufacturing complex APIs, high-potency products, specialty therapeutics, biologics, and advanced formulations — all under strict global regulatory protocols. Each process is governed with transparency, robust documentation, and tight quality control to meet both European and international standards.

Manufacturing Strengths

  • Precision & Compliance: Rigorous quality management aligned with EU GMP and global authorities

  • Advanced Infrastructure: Facilities designed for complex and high-value pharmaceutical products

  • End-to-End Production: Seamless execution from technology transfer to commercial supply

CONTRACT DEVELOPMENT

Shilpa Pharma’s Contract Development services provide German pharmaceutical and biotech partners with innovative, compliant, and scalable drug development solutions tailored to exact regulatory and commercial needs. Building on strong scientific expertise and advanced R&D infrastructure, we support every stage — from route scouting and process optimization to formulation development and pilot-scale manufacturing.

Our teams work closely with German clients to deliver robust development pathways that are fully aligned with EU and global regulatory expectations. This ensures efficient technology transfer, scalable processes, and strong data packages for regulatory filings and market entry.

Need More Clarity?

Work with a trusted CMO/CDMO contract manufacturing organisation in India. Contact us today to discuss your custom development and manufacturing needs.

Questions & Answers

Our FAQ's

Shilpa Pharma offers end-to-end CDMO services, including contract development, API and formulation manufacturing, analytical support, and commercial production tailored to EU and global regulatory standards.

Yes. Shilpa Pharma’s facilities are EU GMP certified and meet benchmark regulatory guidelines from major agencies, ensuring products meet European and global compliance expectations.

India offers cost-efficient expertise, advanced technology, and global regulatory compliance, allowing German companies to scale development and manufacturing without heavy capital investments.

Yes. We specialize in high-potency APIs, complex generics, oncology compounds, and specialty intermediates with strict quality control and documentation.

Our development and manufacturing programs include documentation and data packages aligned with EU and global regulatory requirements to assist with submissions and compliance.

 We maintain robust quality systems, transparent operations, and dependable manufacturing schedules to ensure consistent supply and on-time delivery.

We support oncology, high-potency APIs, biologics, specialty therapeutics, peptides, polymers, and complex molecules.

Yes. Our facilities also hold USFDA, WHO-GMP, and other global approvals, supporting broad regulatory acceptance.

 Key benefits include cost reduction, scalable capacity, regulatory expertise, and access to advanced scientific and manufacturing capabilities.

We maintain end-to-end traceability, validated systems, and extensive quality control mechanisms aligned with EU GMP and global standards.

Countries We Serve in

End-to-End CDMO Services in Germany by Shilpa Pharma

At Shilpa Pharma, we deliver world-class Contract Development and Manufacturing Organization (CDMO) services to pharmaceutical and biotechnology companies in Germany. As a trusted global CDMO partner, we help accelerate product development, ensure regulatory compliance, and optimize manufacturing efficiency. With our proven expertise in drug substance manufacturing, formulation development, and large-scale production, we bring your innovations to life with precision and reliability. Whether you require end-to-end CDMO services in Germany or specialized CDMO biologics solutions, Shilpa Pharma offers flexible, scalable, and cost-effective options tailored to your specific development and commercial goals.

What is CDMO?

A Contract Development and Manufacturing Organization (CDMO) provides integrated drug development and manufacturing services to pharmaceutical and biotech firms. From formulation design and clinical trial material production to full-scale commercial manufacturing, CDMOs handle the complete product lifecycle. This partnership enables companies to focus on innovation, research, and patient care, while leveraging expert technical capabilities and global compliance support.

Why Pharmaceutical Companies Choose Shilpa Pharma for CDMO Services in Germany

Global pharmaceutical firms partner with Shilpa Pharma for our seamless blend of Indian manufacturing excellence and European quality standards. Our reputation as a leading global CDMO is built on innovation, compliance, and client trust.

Here’s why companies in Germany choose Shilpa Pharma:

    • High-Quality Standards: We meet global regulatory norms including EU GMP, USFDA, and WHO compliance.

    • Cost Efficiency: Competitive pricing without compromising technology or product integrity.

    • Skilled Scientific Expertise: A dedicated team of experienced scientists, chemists, and engineers with global project experience.

    • Regulatory Strength: Proven track record with multiple international approvals and audits.

    • End-to-End Capabilities: From R&D and formulation to packaging and logistics — we cover it all under one roof.

Advantages of Our CDMO Services in Germany

Partnering with Shilpa Pharma for CDMO solutions delivers clear advantages:

  • Accelerated Time-to-Market: Streamlined development processes for faster launches.

  • Scalability: Flexible capacity for both small-batch and commercial-scale production.

  • Regulatory Expertise: In-depth understanding of EMA and global compliance standards.

  • Innovation & R&D Support: Access to advanced laboratories and formulation technologies.

  • Reduced Risk: Shared technical, operational, and compliance responsibility.

Global Regulatory Approvals and Compliance

As a globally recognized CDMO in India, Shilpa Pharma’s manufacturing facilities meet the highest international quality standards. Our plants hold multiple global certifications and approvals that reflect our dedication to excellence and compliance.

Our facilities are:

  • USFDA Approved (United States Food & Drug Administration)

  • EU GMP Certified (European Union Good Manufacturing Practice)

  • ANVISA Approved (Brazilian Health Regulatory Agency)

  • COFEPRIS Approved (Mexico)

  • TGA Certified (Australia)

  • PMDA Approved (Japan)

  • KFDA Certified (South Korea)

These certifications position Shilpa Pharma as a trusted CDMO pharma company for both regulated and semi-regulated markets around the world.

Why Choose Shilpa Pharma for CDMO in India?

Ranked among the top global CDMO companies, Shilpa Pharma is recognized for its innovation-driven approach, uncompromised quality, and transparent partnerships.

Our Key Strengths:

    • Comprehensive Expertise: From formulation to final product, we deliver complete CDMO solutions.

    • Advanced Infrastructure: Equipped with state-of-the-art technology and GMP-compliant facilities.

    • Global Reach: Serving pharmaceutical companies across Europe, Japan, China, and other markets.

    • Quality Commitment: Adherence to global compliance and best manufacturing practices.

    • Collaborative Partnership: We value transparency, flexibility, and on-time delivery.

Trusted by Global Markets

Our commitment to excellence, reliability, and innovation has made Shilpa Pharma the preferred CDMO services provider for companies across Germany, Europe, Japan, and beyond. We take pride in our ability to bridge global standards with cost-effective, efficient solutions — helping clients achieve success in competitive pharmaceutical markets.

Fill the Form